Biomarkers of aortic valve stenosis: Should we rely on a single one?
暂无分享,去创建一个
[1] T. Çimen,et al. Calcific aortic stenosis and its correlation with a novel inflammatory marker, the lymphocyte/monocyte ratio. , 2016, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[2] S. Akdağ,et al. Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[3] M. Pencina,et al. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. , 2015, American heart journal.
[4] A. Avcı,et al. The Relationship between Neutrophil/Lymphocyte Ratio and Calcific Aortic Stenosis , 2014, Echocardiography.
[5] J. Park,et al. Association of inflammation, myocardial fibrosis and cardiac remodelling in patients with mild aortic stenosis as assessed by biomarkers and echocardiography , 2014, Clinical and experimental pharmacology & physiology.
[6] Dong Chen,et al. Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study). , 2013, The American journal of cardiology.
[7] P. Kala,et al. Prognostic Utility of Biomarkers in Predicting of One-Year Outcomes in Patients with Aortic Stenosis Treated with Transcatheter or Surgical Aortic Valve Implantation , 2012, PloS one.
[8] A. Leite-Moreira,et al. Understanding the molecular and cellular changes behind aortic valve stenosis. , 2012, Current pharmaceutical biotechnology.
[9] K. Teo,et al. Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis. , 2011, American heart journal.
[10] A. Galloway,et al. Validation of plasma biomarkers in degenerative calcific aortic stenosis. , 2010, The Journal of surgical research.
[11] R. Sainger,et al. Insights into the use of biomarkers in calcific aortic valve disease. , 2010, The Journal of heart valve disease.
[12] K. Teo,et al. Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.
[13] J. Chambers,et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.
[14] R. Prescott,et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.
[15] J. Garot,et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. , 2004, European heart journal.
[16] C D Naylor,et al. Analysis of deaths while waiting for cardiac surgery among 29 293 consecutive patients in Ontario, Canada , 1998, Heart.
[17] Helmut Baumgartner,et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .